Hal C Charles
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Hal C Charles sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Hal C Charles: 7 sponsored US clinical trials, none currently recruiting.
Hal C Charles sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is COPD, with 2 trials.
Upper-quartile sponsor footprint
Hal C Charles sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
19F Thoracic Radiotherapy for Lung Cancer
NCT03315065
Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)
NCT03237364
Lung Transplant Subjects Using 19F MRI
NCT02019251
Imaging Regional Lung Defect Severity
NCT01640288
Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)
NCT01621386
Imaging Lung Function Using Oxygen Enhanced MRI
NCT01731015
Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen
NCT01710449
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
Therapeutic Areas
How the Hal C Charles early-phase archive is shaped
7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).
Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: COPD (2 trials), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Hal C Charles: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Hal C Charles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Hal C Charles page
7 registered trials is a research-attention snapshot, not an endorsement of Hal C Charles or any single study.
- None of Hal C Charles's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- COPD is the condition Hal C Charles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See COPD trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hal C Charles pipeline card: 7 registered trials from official public datasets.Report a data error.